Patent ID: 11965884
Assignee: ALEXION PHARMACEUTICALS, INC.
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 7:
8. The method of claim 7, wherein the patient has been treated with an antibody comprising:
(a) heavy chain CDR1, CDR2, CDR3 domains having the sequences of SEQ ID NOs: 9, 10, 11 and light chain CDR1, CDR2, and CDR3 domains having the sequences of SEQ ID NOs: 12, 13, and 14; or
(b) heavy chain CDR1, CDR2, CDR3 domains having the sequences of SEQ ID NOs: 28, 29, 11 and light chain CDR1, CDR2, and CDR3 domains having the sequences of SEQ ID NOs: 12, 13, and 14.